The following constitutes Amendment No. 5 (“Amendment No. 5”) to the Schedule 13D filed by the undersigned. This Amendment No. 5 amends the Schedule 13D as specifically set forth.
Item 3. | Source and Amount of Funds or Other Consideration. |
Item 3 is hereby amended and restated to read as follows:
The aggregate purchase price of the 855,687 Shares owned by Crescendo Partners II is approximately $4,286,991, including brokerage commissions. The Shares owned by Crescendo Partners II were acquired with partnership funds.
Item 5. | Interest in Securities of the Issuer. |
Item 5(a) is hereby amended and restated to read as follows:
(a) The aggregate percentage of Shares reported owned by each person named herein is based upon 19,588,378 Shares outstanding, which is the total number of Shares reported to be outstanding as of May 9, 2011 in the Issuer’s Quarterly Report on Form 10-Q, as filed with the Securities and Exchange Commission on May 11, 2011.
As of the date hereof, Crescendo Partners II beneficially owns 855,687 Shares, constituting approximately 4.4% of the Shares outstanding. As the general partner of Crescendo Partners II, Crescendo Investments II may be deemed to beneficially own the 855,687 Shares owned by Crescendo Partners II, constituting approximately 4.4% of the Shares outstanding. As the managing member of Crescendo Investments II, which in turn is the general partner of Crescendo Partners II, Mr. Rosenfeld may be deemed to beneficially own the 855,687 Shares owned by Crescendo Partners II, constituting approximately 4.4% of the Shares outstanding. Mr. Rosenfeld has sole voting and dispositive power with respect to the 855,687 Shares owned by Crescendo Partners II by virtue of his authority to vote and dispose of such Shares. Crescendo Investments II and Mr. Rosenfeld disclaim beneficial ownership of the Shares held by Crescendo Partners II, except to the extent of their pecuniary interest therein.
Item 5(c) is hereby amended to add the following:
(c) Schedule A annexed hereto lists all transactions in the Shares since the filing of Amendment No. 4 to the Schedule 13D. All of such transactions were effected in the open market.
Item 5(e) is hereby amended and restated to read as follows:
(e) As of June 8, 2011, the Reporting Persons ceased to be beneficial owners of more than 5% of the securities of the Issuer.
SIGNATURES
After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: June 28, 2011 | CRESCENDO PARTNERS II, L.P., SERIES BB |
| |
| By: | Crescendo Investments II, LLC |
| | General Partner |
| | |
| By: | |
| Name: | Eric Rosenfeld |
| Title: | Managing Member |
| | |
| CRESCENDO INVESTMENTS II, LLC |
| | |
| By: | |
| Name: | Eric Rosenfeld |
| Title: | Managing Member |
| | |
| | |
| |
| ERIC ROSENFELD |
SCHEDULE A
Transactions in the Shares Since the Filing of Amendment No. 4 to the Schedule 13D
Shares of Common Stock (Sold) | Price Per Share ($U.S.) | Date of (Sale) |
| | | |
CRESCENDO PARTNERS II, L.P., SERIES BB |
(100,000) | 6.6263 | 6/07/2011 | |
(60,200) | 6.5395 | 6/08/2011 | |
(11,700) | 6.5619 | 6/09/2011 | |
(1,000) | 6.6000 | 6/10/2011 | |
(11,600) | 6.5141 | 6/16/2011 | |
(7,100) | 6.5186 | 6/17/2011 | |
(56,200) | 6.5171 | 6/21/2011 | |
(6,600) | 6.5056 | 6/22/2011 | |
(25,000) | 6.5494 | 6/24/2011 | |